These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 8061014

  • 1. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Kirklin JK, Naftel DC, Levine TB, Bourge RC, Pelletier GB, O'Donnell J, Miller LW, Pritzker MR.
    J Heart Lung Transplant; 1994; 13(3):394-404. PubMed ID: 8061014
    [Abstract] [Full Text] [Related]

  • 2. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO, Naftel DC, Seib PM, Pearce FB, Addonizio LJ, Kirklin JK, Morrow WR.
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [Abstract] [Full Text] [Related]

  • 3. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.
    Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, Jarcho J, Hobbs RE, Mills RM.
    J Heart Lung Transplant; 1994 Dec; 13(3):381-92; discussion 393. PubMed ID: 8061013
    [Abstract] [Full Text] [Related]

  • 4. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.
    Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora JL.
    J Heart Lung Transplant; 1994 Dec; 13(3):353-64; discussion 364-5. PubMed ID: 8061010
    [Abstract] [Full Text] [Related]

  • 5. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Bourge RC, Naftel DC, Costanzo-Nordin MR, Kirklin JK, Young JB, Kubo SH, Olivari MT, Kasper EK.
    J Heart Lung Transplant; 1993 Dec; 12(4):549-62. PubMed ID: 8369318
    [Abstract] [Full Text] [Related]

  • 6. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
    Mahle WT, Fourshee MT, Naftel DM, Alejos JC, Caldwell RL, Uzark K, Berg A, Kanter KR, Pediatric Heart Transplant Study Group.
    J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
    Kubo SH, Naftel DC, Mills RM, O'Donnell J, Rodeheffer RJ, Cintron GB, Kenzora JL, Bourge RC, Kirklin JK.
    J Heart Lung Transplant; 1995 Dec; 14(3):409-18. PubMed ID: 7654724
    [Abstract] [Full Text] [Related]

  • 8. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, McGiffin DC, Kirklin JK.
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [Abstract] [Full Text] [Related]

  • 9. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [Abstract] [Full Text] [Related]

  • 10. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].
    Colombo T, Borrello B, Lanfranconi M, Pomé G, Quaini E, Russo C, Vitali E, Grassi M, Frigerio M, Gronda E, Mangiavacchi M, Merli M, Pellegrini A.
    G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710
    [Abstract] [Full Text] [Related]

  • 11. Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.
    Colombo T, Vitali E, Lanfranconi M, Russo C, Bruschi G, Marchetti C, Colucci V, Frigerio M, Oliva F, Grassi M, Gronda E, Merli M, Pellegrini A.
    Clin Transpl; 1998 Jan; ():315-25. PubMed ID: 10503110
    [Abstract] [Full Text] [Related]

  • 12. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.
    Clin Transpl; 2003 Jan; ():89-100. PubMed ID: 15387100
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P, Kübrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M.
    Circulation; 2004 Sep 14; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [Abstract] [Full Text] [Related]

  • 14. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Kobashigawa JA, Kirklin JK, Naftel DC, Bourge RC, Ventura HO, Mohanty PK, Cintron GB, Bhat G.
    J Heart Lung Transplant; 1993 Sep 14; 12(3):355-66. PubMed ID: 8329404
    [Abstract] [Full Text] [Related]

  • 15. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.
    Transpl Infect Dis; 2000 Sep 14; 2(3):112-7. PubMed ID: 11429021
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May 14; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 17. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R, Minoli L, Parolini M, Gavazzeni G, Gentile M, Grossi P, Livi U, Parisi F, Utili R.
    J Heart Lung Transplant; 1996 Feb 14; 15(2):124-35. PubMed ID: 8672515
    [Abstract] [Full Text] [Related]

  • 18. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
    Bacigalupo A, Tedone E, Sanna MA, Moro F, Van Lint MT, Grazi G, Balestreri M, Frassoni F, Occhini D, Gualandi F.
    Haematologica; 1992 Feb 14; 77(6):507-13. PubMed ID: 1337746
    [Abstract] [Full Text] [Related]

  • 19. Redo lung transplantation: a North American-European experience.
    Novick RJ, Kaye MP, Patterson GA, Andréassian B, Klepetko W, Menkis AH, McKenzie FN.
    J Heart Lung Transplant; 1993 Feb 14; 12(1 Pt 1):5-15; discussion 15-6. PubMed ID: 8382951
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.
    Clin Transplant; 1997 Oct 14; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.